TOP TIERMARKET NEWSWIRE
SEC Form 4 history

CUE BIOPHARMA INC (CUE) insider trades

CUE BIOPHARMA INC (CUE) insider trading activity (SEC Form 4). Over the trailing 90 days, CUE insiders filed 0 purchases totalling $0 and 6 sales totalling $2.4M — net SELLING of $2.4M. Most recent filing: Oct 14, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
6
$2.4M
Net (90d)
-$2.4M
net selling
Most recent
Oct 14, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Oct 14, 2026Ray SumitaChief Legal Compliance OfficerS Sale—$28.05$52Kfiling
Oct 14, 2026Meluzio Michael VincentVP, Prin. Accounting OfficerS Sale—$28.05$32Kfiling
Oct 14, 2026Lin Shao-LeeCEOS Sale—$27.55$305Kfiling
Aug 17, 2026Ray SumitaChief Legal Compliance OfficerS SaleOE—$30.09$266Kfiling
Aug 17, 2026Meluzio Michael VincentVP, Prin. Accounting OfficerS SaleOE—$30.09$169Kfiling
Aug 14, 2026Lin Shao-LeeCEOS SaleOE—$27.58$1.6Mfiling